Yes, ulcerative colitis (UC) can start in your 60s, 70s or later, and it is not rare. In a Swedish nationwide study of everyone newly diagnosed with inflammatory bowel disease (IBD) between 2006 and 2013, 23% were 60 or older at diagnosis, and UC was the most common type in that group (Everhov 2018). What changes with age is less the disease itself than everything around it: the list of conditions that look like colitis gets longer, the usual screening test gets less reliable, and the trade-offs of treatment shift because of frailty, other illnesses and the number of medicines already in the cupboard.
This guide is for people diagnosed later in life and, just as often, for the adult children trying to help them. The questions come from patient communities, where the most common posts on this topic are written by a son or daughter: can you really get this at 66, why did it take so long to find, is it milder when it starts late, and what else could it be? The answers come from population registries, hospital cohorts and guidelines, and in several places those sources disagree. Where they do, we show both sides rather than picking the more reassuring one. Where we say we could not find evidence, that reflects our searching of PubMed and Europe PMC, not proof that none exists.
Can you really develop ulcerative colitis in your 60s, 70s or 80s?
Yes. UC is most often diagnosed in young adults, but a meaningful share of new cases appear later, and the numbers are not small. The Swedish study above counted 27,834 people with newly diagnosed IBD, of whom 6,443 were 60 or older, giving an incidence in that age group of about 19 new UC cases per 100,000 people per year (Everhov 2018). Put the other way round, that is roughly one new UC diagnosis a year for every 5,000 people over 60, which is uncommon for any one person but adds up to a lot of patients across a population.
Other sources give similar proportions using different age cut-offs. An expert review from the American Gastroenterological Association advises that IBD should be considered in older people with diarrhoea, rectal bleeding, urgency, abdominal pain or weight loss "because up to 15% of new diagnoses of IBD occur in individuals older than 60 years" (Ananthakrishnan 2021). A US analysis of hospital admissions put the proportion of IBD cases appearing after 65 at about 15% (Ananthakrishnan 2009). A word on how we read the AGA review: its full text was paywalled to us, so we quote only the three diagnostic statements we could read verbatim, and we do not describe anything else it says.
In a French population registry of people diagnosed with IBD after 60, the median age at UC diagnosis was 69, with the middle half of patients diagnosed between 64 and 74 (Charpentier 2014). A US tertiary-centre study plotting age at diagnosis found two peaks, one in young adulthood and a second later in life (Ha 2010). The oldest person in its late-onset group was 87.
So when a family is "baffled at how old he is to have it pop up", as one adult child put it in a thread about a father diagnosed at 66, the surprise is understandable but the diagnosis is not unusual. The replies in that thread are full of people who were diagnosed at 48, 52, 62, 65 and 70.
What counts as "late onset"? There is no single definition
There is no agreed age cut-off, and this matters more than it sounds. Researchers use different thresholds:
- 50 and over: the US tertiary-centre study that is often quoted as showing late onset UC "has better outcomes" defined late onset as diagnosis at 50 or older and compared it with diagnosis between 18 and 30 (Ha 2010). The mean age of its late-onset group was 60.
- 60 and over: most population studies and the AGA review use 60 (Charpentier 2014; Everhov 2018).
- Over 65: some treatment-safety studies use 65 (Cottone 2011; Parian 2015).
Medical papers usually say "elderly-onset" for 60 and over, which many readers find off-putting. We use "late onset" and "older" here, but they mean the same thing. When you see a confident claim about late onset UC, the first question is: compared with whom, and starting at what age? A 52-year-old and an 82-year-old are both "late onset" in some studies, and they are very different patients.
Why would ulcerative colitis start now?
Nobody can tell an individual why their UC started, and that includes at 66. That is the honest answer to the uncle in the Reddit thread who wanted the family to find "a doctor who will tell us what caused the UC". What researchers can describe are patterns across large groups, and several of them are different in people diagnosed later.
Family history is less common, former smoking is more common. In the US tertiary-centre study, 10.7% of the late-onset group had a relative with IBD, against 21.3% of the early-onset group. About half of the late-onset group were former smokers, against 13.5% of those diagnosed between 18 and 30 (Ha 2010). The smoking-cessation pattern is real and well documented, and the detail of why, and what it does and does not mean for anyone thinking about cigarettes, is covered in our post on whether smoking helps ulcerative colitis. The short version is that it is not a reason to smoke.
UC may be triggered later in life in a way Crohn's is not. One group of European epidemiologists has proposed that Crohn's disease is shaped largely by early-life exposures, whereas in UC the harmful shift in gut bacteria "could occur at any time of life, due to instant environment" (Beaugerie 2018). That paper is a hypothesis, published in a journal for hypotheses, and should be read as an idea that fits the data rather than a proven mechanism.
Antibiotics are linked with new IBD at every age, most strongly in middle and later life. A Danish nationwide study followed more than six million people aged 10 and over. Antibiotic use was linked with a higher rate of new IBD in all age groups, with incidence rate ratios of 1.28 at ages 10 to 40, 1.48 at 40 to 60, and 1.47 at 60 and over. The link grew with the number of courses, was strongest one to two years after exposure, and was strongest for the antibiotic classes often used for gut infections (Faye 2023). Two cautions apply. These are relative increases on a small baseline risk, and an observational study cannot rule out that the infection, or early unrecognised colitis being treated as an infection, explains part of the link. In the father's thread, one person described being diagnosed at 70 after heavy courses of several antibiotics, and another said their mother's antibiotic-linked colitis went away within a few months. That last point is worth taking seriously: a short antibiotic-associated colitis that resolves is not UC, which is one reason a firm diagnosis rests on biopsies, not on the story alone.
Microscopic colitis comes first in some people. Microscopic colitis is commonest in older adults, with a median age at diagnosis over 60 (Miehlke 2021). In a Swedish study of 13,957 people with microscopic colitis, the rate of later UC was about 17 times higher than in matched people without it, but the absolute excess was 2.6 percentage points over 10 years (Khalili 2020). In other words, most people with microscopic colitis never develop UC, but a small minority do, on average about three years later.
Diet quality did not predict late onset UC. In two Swedish cohorts of 83,147 adults followed for 20 years, healthier diet scores were linked with less late onset Crohn's disease, but none of the four diet scores was associated with the risk of UC (Khalili 2023). For families wondering whether a parent "brought it on" through what they ate, that is a useful finding. In the same cohorts, 395 people developed UC over the study, about one in 210 participants.
Does ulcerative colitis look different when it starts later?
Often a little, yes. On average, late onset UC is more often confined to the rectum or the left side of the colon, and the oldest patients may have fewer of the textbook symptoms.
In the French registry, 29% of people diagnosed after 60 had proctitis (rectum only), 45% had left-sided colitis and 26% had extensive colitis, and the disease did not spread further during follow-up in 84% of them (Charpentier 2014). A later analysis of the same French registry split patients at 70. Those diagnosed between 60 and 69 had more rectal bleeding (86% against 79%) and more abdominal pain (44% against 34%), while those diagnosed at 70 or older more often had left-sided colitis (62% against 49%) (Duricova 2018). The bleeding difference did not reach statistical significance, the other two did. For conditions that can look like ulcerative colitis, see what can be mistaken for ulcerative colitis.
A two-centre Chinese hospital study comparing 68 people diagnosed at 60 or over with 136 diagnosed younger found the older group had milder symptoms, less abdominal pain and less mucus and blood in the stool, more proctitis, and more other illnesses alongside the colitis. Its authors concluded that the milder picture creates "challenges for clinical diagnosis" (Li 2026). Not every study agrees: the US tertiary-centre study found disease extent and symptom severity at diagnosis were similar between its early and late groups (Ha 2010).
What this means in practice is that a later-life UC presentation may be quieter than the one people imagine. Looser stools that will not settle, urgency, some mucus, a bit of blood that is easily blamed on haemorrhoids, tiredness from slow blood loss. If you are wondering how much blood is too much, or how to tell colitis bleeding from haemorrhoids, our post on blood in the stool with UC covers that in detail.
What else can it be? The look-alikes that matter after 60
This is the section that matters most if you, or a parent, have new bowel symptoms later in life. Several conditions that cause bloody or persistent diarrhoea become more common with age, and some of them need very different treatment from UC. The US tertiary-centre study is a good illustration: before comparing age groups, it had to exclude people whose colitis turned out to be segmental colitis associated with diverticulosis, ischaemic colitis or a tumour (Ha 2010).
| Condition | How it typically behaves | Why it matters |
|---|---|---|
| Ischaemic colitis (reduced blood flow to the colon) | Sudden cramping pain low on the left, an urgent need to go, then bloody stool within about 24 hours. Most cases are in people over 60 and settle within days to two weeks (Ahmed 2021) | Usually short-lived and treated by supporting blood flow, not by long-term immune treatment |
| Segmental colitis associated with diverticulosis (SCAD) | Inflammation between diverticula, usually in the sigmoid colon, with the rectum and right colon typically spared; mean age at diagnosis in one series was 62.5 (Samasca 2026) | Can look like UC through the scope; the AGA review specifically flags it in older people with left-sided colitis and diverticulosis (Ananthakrishnan 2021) |
| Microscopic colitis | Chronic watery, non-bloody diarrhoea, with a colon that looks normal or nearly normal on colonoscopy; median age at diagnosis over 60 (Miehlke 2021) | Only biopsies show it; chronic use of PPIs, NSAIDs or SSRIs is associated with it, though the guideline stresses that this does not prove cause |
| Infection, including C. difficile | Can cause bloody diarrhoea and inflammation that looks like colitis | Older adults are more vulnerable to dehydration and complications from diarrhoea (Shane 2017) |
| Bowel cancer or large polyps | Bleeding, change in bowel habit, anaemia, weight loss | Risk rises with age; the AGA review names colorectal neoplasia among the reasons for colonoscopy (Ananthakrishnan 2021) |
| Haemorrhoids | Bright red blood on the paper or on the surface of a normal stool | Common and often blamed first, which can delay finding colitis |
A few of these deserve more detail.
Ischaemic colitis has a recognisable story. Most cases happen when blood flow to part of the colon drops briefly, the left side and the splenic flexure are the usual sites, and about 85% of cases are non-gangrenous, transient and self-limiting (Ahmed 2021). The sequence of sudden cramping, urgency and then blood within a day is a different story from weeks of creeping diarrhoea. Our post on left-sided abdominal pain has more on how ischaemic colitis presents.
SCAD can mimic UC closely. The classic pattern is inflammation in the segment of colon with diverticula, with the rectum spared. UC typically starts in the rectum and extends upwards, so rectal sparing is a clue, but a 2026 review warns that this "rule of sparing" is not definitive and that biopsies from several regions, including the rectum, remain essential (Samasca 2026). Diverticula themselves are very common at this age: the same review cites figures of more than 70% of people aged 65 and over in Western populations.
Microscopic colitis is invisible without biopsies. The European guideline describes it as chronic watery, non-bloody diarrhoea with a normal or almost normal-looking colon, and recommends that it be ruled out in people who meet the criteria for a functional bowel disorder, especially when they have risk factors or do not respond to IBS treatment (Miehlke 2021). If your colonoscopy was "normal" but nobody took biopsies, that is worth asking about. For the wider work-up of persistent watery diarrhoea, our Bristol type 7 guide has the details.
Infection has to be looked for every time. Infections can produce colitis that looks like UC, and they can also complicate UC that is already there, so stool testing is a routine part of the work-up. The Reddit thread about the 66-year-old father illustrates the confusion families face: he was given antibiotics for an infection during his first flare, and one reply insisted it must therefore be C. difficile rather than UC. His family said he had tested negative. Both things can be true at different times, which is why stool testing is part of the work-up.
Why the usual screening test works less well in older people
In younger adults with diarrhoea, a stool test called faecal calprotectin is often used to decide who needs a colonoscopy. The British Society of Gastroenterology's IBS guideline recommends it specifically for people under 45 with diarrhoea, and notes that calprotectin "is not specific to IBD and can be elevated in older age groups (age ≥45 years), obesity, infection, malignancy or by medications, such as proton pump inhibitors (PPIs) or non-steroidal anti-inflammatory drugs (NSAIDs)" (Vasant 2021).
That list reads like a description of many people over 60. The AGA review takes the same line from the other direction: calprotectin or lactoferrin "may help prioritize patients with a low probability of IBD", but people with bloody stools or chronic diarrhoea and an intermediate to high suspicion of IBD, microscopic colitis or colorectal neoplasia "should undergo colonoscopy" (Ananthakrishnan 2021). So if a parent's calprotectin came back raised, it does not prove UC, and if it came back modest, that does not settle things either. Once UC is diagnosed, calprotectin becomes much more useful for tracking it over time; our calprotectin guide explains how to read those numbers.
Why did it take so long to diagnose?
We could not find a study that measured diagnostic delay specifically in people diagnosed with UC after 60, so we cannot give you a number, and any page that does should show its source. What the evidence does show is why delay is plausible: the look-alikes above are common at this age, the stool test is less decisive, older patients may have milder symptoms, and many are already taking medicines that change bowel habits.
The lived experience is consistent. In a thread asking whether people would rather have got IBD at an older age, one person described decades of symptoms dismissed as stress, haemorrhoids or IBS, and only getting a scope with biopsies once they were old enough for doctors to think about cancer. Another, diagnosed at 62, had spent a decade believing they had a wheat sensitivity. In the father's thread, others describe the opposite: a sudden, dramatic start with no warning, including one person who spent a couple of weeks in hospital before anyone could name it. Both patterns appear repeatedly.
Is late onset ulcerative colitis milder or more severe?
The honest answer is that it depends on which study you read, and the studies are measuring different things. Population registries, which count everyone, describe a mostly mild course. Hospital studies, which count people sick enough to be admitted, find older patients do worse. Both are probably true at once.
Here is the evidence side by side.
| Study | Who was counted | What it found |
|---|---|---|
| Ha 2010, US tertiary centre | 140 diagnosed at 50+ vs 155 diagnosed at 18 to 30 | More steroid-free remission at one year in the late group (64% vs 49%); first-year UC hospital stays were similar (66 vs 57), though the gap became significant when only people diagnosed at 60+ were counted |
| Charpentier 2014, French population registry | 472 with UC diagnosed after 60 | Colectomy in 4% by one year and 8% by 10 years; authors call the course "mild" |
| Duricova 2018, same French registry | 276 diagnosed 60 to 69 vs 189 diagnosed 70+ | Steroid resistance more common in the 60s group (12% vs 3%); similar surgery rates |
| Everhov 2018, Swedish nationwide | 6,443 with IBD diagnosed at 60+ | More hospital admissions and more bowel surgery than adult-onset IBD (13% vs 10% at five years), fewer biologics, more steroids |
| Okabayashi 2022, 27 hospitals | 83 older-onset vs 384 younger-onset, all admitted with moderate to severe UC | Remission at day 30 on IV steroids 52% vs 66%; surgery within 90 days 20.5% vs 3.1%; four deaths, all older-onset |
| Moroi 2024, Japanese claims database | Older patients split by age at onset | Late onset linked with more systemic steroids and higher mortality, but not more biologic use or surgery |
| Sawahashi 2024, single Japanese centre | 30 diagnosed at 60+ vs 67 older people diagnosed younger | Late onset group started steroids and targeted drugs sooner after onset (46% vs 22% on steroids at one year) |
| Li 2026, two Chinese hospitals | 68 diagnosed at 60+ vs 136 younger | Milder symptoms, no difference in remission, relapse or complications |
How can these all be right? Three things reconcile most of it.
First, who gets counted. A population registry includes the 70-year-old with mild proctitis managed on suppositories who never sees a hospital ward. A study of hospital admissions does not. If most late onset UC is limited and manageable, but the minority that turns severe does badly, both pictures are accurate. The Swedish study shows this tension inside one dataset: older patients had less IBD-specific outpatient care but more IBD-related hospital admissions.
Second, treatment is an outcome chosen by doctors. "Fewer biologics" can mean milder disease or more cautious prescribing. The Swedish authors say exactly this: the large differences in treatment between adults and older patients "are not necessarily because of a milder course of disease and warrant further investigation" (Everhov 2018). An editorial in the journal that published the Okabayashi study put the same question in its title: is older-onset UC more severe, or less aggressively managed (Fernandes 2022)? We could not read that editorial, so we cite it only for the question it poses.
Third, the comparison group changes. Ha compared people in their 60s with people in their 20s. Sawahashi compared people over 60 who were diagnosed late with people over 60 who had had UC for decades. Those are different questions, and the second one found the late onset group needed stronger treatment sooner.
Reddit threads reflect the same split. In a discussion of UC severity with age, one person diagnosed at 62 described a mild clinical picture despite a biopsy report labelled severe, while another described an 81-year-old mother hospitalised twice with UC and only partly controlled on combination treatment. Several longer-standing patients said their own UC had quietened over decades, and others said it had not. There is no published dataset we found that tracks whether UC you have had since your 20s becomes milder as you age, so nobody can promise that it will.
When late onset UC turns severe
When it is severe, age raises the stakes, and that is the main reason not to sit on worsening symptoms. In a US national database of IBD hospital admissions in 2004, patients over 65 made up about a quarter of all IBD-related admissions and, even after adjusting for other illnesses, had about four times the odds of dying in hospital compared with younger patients (odds ratio 3.91) (Ananthakrishnan 2009). That study included both Crohn's disease and UC.
In the multicentre study of people admitted with moderate to severe UC, the older-onset group not only responded less often to IV steroids but also had more complications within 90 days: infection in 18.1% against 8.6%, and venous blood clots in 7.2% against 0.5% (Okabayashi 2022). In the Japanese claims database, late onset UC was linked with higher mortality even though surgery rates were similar, and the authors called for attention to "appropriate timing of surgery" in older patients (Moroi 2024).
None of this means surgery is the likely outcome for most people. In the French registry, 92% of people with late onset UC still had their colon 10 years after diagnosis (Charpentier 2014). It means that when a flare is severe, the window for safely trying another medicine is shorter, and decisions about surgery may need to happen sooner than they would for a 30-year-old. If surgery does come up, our post on life after colectomy for UC covers what follows. For the signs that a flare needs hospital care, see when to go to the hospital for a UC flare.
How treatment trade-offs change after 60
The medicines used for UC are the same at 30 and at 75. What changes is the balance of benefit and risk, and that balance depends much more on frailty, other illnesses and the rest of your medicine list than on your age. This section explains the evidence behind those trade-offs. It is not advice to start, stop or change anything: every decision here belongs with your IBD team.
Steroids: easy to start, easy to keep using too long
Steroids work fast and are familiar, which is part of why older people get more of them. In Sweden, people diagnosed with IBD at 60 or over received fewer biologics and immunomodulators but more systemic corticosteroids than younger adults (Everhov 2018). In a US tertiary-centre study of 190 people with IBD aged 65 or older, 40% had been prescribed chronic steroids, including 24% who were in remission or had only mild disease. The same group took an average of nine routine medicines, 43% had severe polypharmacy (ten or more), and almost three quarters had at least one potential drug interaction (Parian 2015).
That matters because steroid side effects, such as bone loss, high blood sugar, infections, mood and sleep changes, weigh more heavily in older bodies. The BSG guideline states that corticosteroids do not have a role in preventing relapse, and recommends escalating maintenance treatment for UC patients who needed two or more steroid courses in the past year or who cannot come off steroids (Lamb 2019). If you or a parent have been on steroids for months, it is a fair question to ask the team whether there is a plan to come off them.
Biologics and immunosuppressants: the infection question
The main worry with immune-suppressing treatment in older people is infection. The older evidence is sobering. In a multicentre study of people treated with anti-TNF drugs between 2000 and 2009, 95 were over 65. During follow-up, 11% of them had a severe infection and 10% died, compared with 0.5% and 2% among people over 65 not given those drugs, and 2.6% and 1% among younger patients on them (Cottone 2011). That was a small group from an earlier era, and the comparison groups were not randomised, so sicker patients may have been more likely to receive anti-TNF drugs. But it shaped a generation of caution.
Newer studies point to a more nuanced picture. In a two-country cohort, vedolizumab, a gut-selective biologic, worked about as well in people aged 60 or over as in people aged 40 or under, with week-52 remission in UC of 48% and 51%. Infections were more common in the older group, at roughly 12% against 2%, and none was fatal (Cohen 2020). Note that the abstract lists those infection figures in the reverse order from the groups it names, so we have read them by the direction its text describes. Several of that study's authors disclosed consultancy or speaker fees from Takeda, which makes vedolizumab; we could not read the study's full funding statement. The BSG guideline notes that vedolizumab "may be preferred" in situations such as "use in older patients where infection and malignancy are a concern", while adding that data to support a clear benefit in any subgroup are limited (Lamb 2019). That passage sits in the guideline's Crohn's disease section, so it should not be read as a UC-specific recommendation.
For thiopurines such as azathioprine, the BSG guideline says the small increase in lymphoma risk applies "particularly in older patients", and that side effects should be weighed in decisions about how long to continue them in older people (Lamb 2019). The detailed lymphoma arithmetic is in our post on night sweats with IBD.
Frailty predicts trouble better than age
The most useful finding for families may be this one. In a study of 11,001 people with IBD, those who met a validated definition of frailty before starting an anti-TNF drug or an immunomodulator had roughly 1.8 to 2 times the adjusted odds of an infection in the following year, after accounting for age, other illnesses, steroids and combination therapy. Infections after anti-TNF treatment occurred in 19% of frail patients against 9% of fit ones (Kochar 2020). Only a minority of that cohort was treated (1,299 with anti-TNF and 2,676 with an immunomodulator), and only 5% to 7% of the treated patients were frail, so the frail groups were small.
What that means in practice: a fit, independent 74-year-old and a frail 74-year-old with heart failure and ten other prescriptions are not the same patient, and decisions should not be made as though they were. Telling the IBD team honestly how much a parent can do day to day, whether they have had falls, and every medicine and supplement they take, gives the team what they need to weigh this properly.
Clairop logs meals, symptoms and stool in seconds, then looks for the foods your gut reacts to, including reactions that land days later.
What the cancer-surveillance rules mean if UC started late
People with UC affecting the colon are offered surveillance colonoscopies because long-standing colitis raises bowel cancer risk. The BSG recommends the first one 8 years after IBD symptom onset, with annual surveillance from diagnosis for anyone with primary sclerosing cholangitis, and the interval after that set by risk (Lamb 2019).
For someone diagnosed at 70, two practical points follow. If symptoms were brushed aside for years before diagnosis, the 8-year clock may already be partly run, which is why the symptom-onset date in the earlier tip matters. And the age-related bowel cancer risk that applies to everyone does not pause while you wait for UC surveillance to begin, which is one more reason the diagnostic colonoscopy at the start is so important. How surveillance fits with other health priorities later in life is an individual conversation with your team.
Other things that are easier to miss at this age
Anaemia and fatigue. Slow blood loss and inflammation both cause iron deficiency, and in older people the tiredness is easily blamed on age. Our post on UC fatigue and low iron covers the tests and why ferritin can mislead during inflammation.
Dehydration. The IDSA guideline on infectious diarrhoea notes that dehydration increases the risk of life-threatening illness and death, "especially among the young and older adults" (Shane 2017). That guideline is about infectious diarrhoea rather than UC, but the physiology of fluid loss is the same. Dizziness on standing, very dark urine, confusion and passing much less urine are reasons to seek help the same day.
Symptoms outside the gut. Joint pain, eye inflammation and skin problems can come with UC at any age. In the Swedish study, these extraintestinal manifestations occurred at similar rates in older and adult-onset patients (Everhov 2018). Our joint pain explainer covers which outside-the-gut symptoms are recognised IBD manifestations. In the thread about getting IBD at an older age, one person diagnosed after retiring at 62 said the joint pain was the worst part of being older with it.
Urgency. Urgency is disruptive at any age but carries particular risks for someone with reduced mobility, poor balance or a long walk to the bathroom. Our post on managing urgency with UC has practical strategies.
If you are the adult child of someone newly diagnosed
The Reddit threads behind this keyword are mostly written by worried children, not by patients, and the people with UC who reply have clear views on what helps.
Do not lead with a cure. In a thread from a student asking how to support a father with UC, the most-upvoted reply was blunt: do not suggest diets, protocols or remedies, because people with the disease already research constantly and being offered a cure feels like an insult. Being present, asking how they are doing, and helping them forget about it for a while ranked far higher.
Help with the practical load. Appointments, test results, insurance or prescription admin, and a single up-to-date list of every medicine and supplement are all things an adult child can take on. Given how common polypharmacy is in older people with IBD (Parian 2015), that list is genuinely useful to the IBD team.
Keep the family conversation on the plan, not the cause. In the 66-year-old father's thread, much of the family's stress came from a relative insisting on finding someone to blame. Researchers cannot identify the cause for an individual, and nothing about the treatment plan depends on it.
Learn the red flags. These are listed in the next section. Adult children are often the ones who notice confusion, dizziness or a parent quietly eating and drinking less to avoid the bathroom.
Think ahead about care settings. One person in the threads worried about what would happen if they were ever in a care home that could not keep up with their medicines or with urgent toilet needs. We found no research on IBD care in residential settings to point you to, but it is a reasonable topic to raise with the IBD nurse if a move is being considered.
What to track in the first months
The first months after a late diagnosis are when the team is working out how extensive the disease is, how it responds, and how much treatment the person tolerates. A few things are worth recording:
- Stool count, blood and urgency each day, the core of the scores most UC teams use. Our guide to knowing whether your UC is flaring explains how those scores work.
- Every medicine change, with dates, including steroid courses and their tapers, and anything started for other conditions. New blood-pressure tablets, a course of antibiotics or a new painkiller can all affect bowel habits.
- Falls, dizziness and fluids, which matter more at this age than in most UC tracking advice written for younger people.
- The date symptoms truly started, for the surveillance reason above.
Our post on what to track in an IBD symptom diary goes through the full set of fields. Clairop can help with the logging side: you can describe a meal or a symptom out loud instead of typing, and it produces a one-page GI visit report covering an activity score, bowel pattern, medication adherence and labs to take into the appointment, which can be easier for an older patient or a family member than keeping a paper diary. Before the appointment itself, our guide to preparing for a GI appointment covers the rest.
Myths about late onset ulcerative colitis
"You're too old to get UC." No. Almost a quarter of new IBD diagnoses in Sweden were in people aged 60 or over (Everhov 2018), and people are diagnosed in their 80s.
"New bowel trouble in your 60s is just IBS." IBS that starts for the first time later in life should not be assumed without proper tests. Guidelines recommend colonoscopy for older people with rectal bleeding or chronic diarrhoea when IBD, microscopic colitis or cancer is a possibility (Ananthakrishnan 2021).
"Late onset UC is always milder." On average it is often less extensive, but in people admitted with severe UC, older-onset patients responded less well to IV steroids and had more surgery, infections and clots (Okabayashi 2022).
"A normal colonoscopy rules out colitis." Not if no biopsies were taken. Microscopic colitis, a common look-alike in this age group, looks normal or nearly normal on camera (Miehlke 2021).
"Older people can't have biologics." Age alone does not rule them out. Vedolizumab worked about as well in people over 60 as in younger patients in one large cohort, though infections were more common (Cohen 2020), and frailty predicted post-treatment infections independently of age (Kochar 2020).
"It must have been caused by something they ate." In 83,147 Swedish adults, no measure of diet quality was linked with the risk of later-onset UC (Khalili 2023). Diet can matter for symptoms once you have UC, which our post on whether food can trigger a UC flare covers, but that is a different question from what started it.
When to see a doctor promptly
New bowel symptoms after 50 or 60 always deserve a proper assessment, not a wait-and-see. See a doctor promptly if you or a parent have:
- Any new rectal bleeding, or blood mixed into the stool
- Diarrhoea lasting more than a few weeks, or a lasting change in bowel habit
- Unexplained weight loss, or loss of appetite
- Night-time symptoms that wake you to go
- Anaemia or unusual tiredness and breathlessness
- A family history of bowel cancer or IBD
The bottom line
Late onset ulcerative colitis is common enough that it should never be dismissed as too unlikely to consider, and different enough that it deserves its own approach. It is often less extensive and, across whole populations, usually manageable without surgery. But the diagnosis is harder because of the look-alikes, the usual stool test is less decisive, and when it is severe, older patients do worse in hospital than younger ones.
The most useful things you can do are practical. Make sure the diagnosis rests on a colonoscopy with biopsies and infection testing. Write down when symptoms really started. Keep one accurate medicine list. Ask whether any steroid course has an end date. Tell the team honestly about frailty, falls and other illnesses, because those shape the safest treatment more than age does. And if you are the adult child reading this at midnight: being there, handling the paperwork and knowing the red flags will help more than finding the cause.
